- The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back Ukraine, the Wall Street Journal reported citing administration officials.
- The White House is asking about $22.4 billion for Covid-19 vaccines, trials, and testing; $3.9 billion to fight against monkeypox; and $4.5 billion to prepare for and recover from natural disasters.
- The administration is also asking for $13.7 billion to continue supporting Ukraine.
- Last month, the White House Covid-19 Response Coordinator said the Biden administration would stop buying COVID-19 vaccines and treatments as the U.S. plans to get out of the crisis phase.
- Congress must vote on a spending bill by the end of September to avoid a partial government shutdown as the lawmakers expect to use a stopgap funding measure that will help maintain funding levels for the short term.
- Spending bills require 60 votes, and in the 50-50 Senate, at least 10 Republicans would need to back any bill that contained the administration’s request.
- In May, Congress passed a nearly $40 billion military and economic aid package to help Ukraine, and lawmakers expect further funding needs as the war continues.
- Photo via Wikimedia Commons
BNTXBioNTech SE
$95.900.05%
BVNKFBavarian Nordic AS
$30.322.97%
BVNRYBavarian Nordic AS
$9.73-0.71%
EBSEmergent BioSolutions Inc
$11.62-2.11%
GOVXGeovax Labs Inc
$0.41774.95%
GSKGSK PLC
$47.470.42%
JNJJohnson & Johnson
$200.300.17%
LLYEli Lilly and Co
$983.000.08%
MRNAModerna Inc
$28.250.04%
PFEPfizer Inc
$25.370.16%
SIGASIGA Technologies Inc
$6.260.16%
TNXPTonix Pharmaceuticals Holding Corp
$19.46-0.71%
VIRVir Biotechnology Inc
$6.66-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
